Sweden / A Global Testbed for AMR Incentive Models
Anders Blanck, CEO of Lif, the trade association for the research-based Swedish pharmaceutical industry, writes…
Opinion
ASEAN / Regulatory Cooperation & Joint Assessments
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
Canada / Concrete Steps Toward National Pharmacare
Writing in the September edition of DIA’s Global Forum magazine, Dr Judith Glennie examines the specific…
USA / Drug Innovations Are Delivering for Patients; We Need Innovation In How They’re Paid For
John M. O’Brien, recently appointed president and CEO of the US National Pharmaceutical Council, calls for…
In Conversation
Exclusive: Thomas Cueni on 50 years of global progress
The past 5 decades have seen monumental strides in healthcare; from the discovery that aspirin prevents blood clotting to the eradication of smallpox. In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reflects on 50 years of innovation from the associations housed under their umbrella and looks towards the biggest challenges healthcare is…
Tae-Han Kim – President & CEO, Samsung Biologics,…
In an exclusive interview, Tae-Han Kim, president and CEO of Samsung Biologics, documents his strategy for expanding Samsung’s operations into biologics, and how Samsung Biologics has rapidly become one of…
Dr Fahrettin Koca – Minister of Health, Republic of…
The Minister of Health of the Republic of Turkey, Dr Fahrettin Koca, provides an overview of the current state of the Turkish healthcare ecosystem, highlighting its opportunities and challenges. He…
Japan / COVID-19: Treatments, Vaccines & Remote Study Audits
Writing in the August edition of DIA’s Global Forum, Kotone Matsuyama of the Nippon Medical School gives a…
Opinion / The Chinese Doctor-Patient Relationship in the Digital Era
I recently had the pleasure to moderate an event on the COVID-19 impact on the relationship between Doctor and…
China / CDE’s Drug Evaluation Report 2020: Part 1
The following is an overview from Accestra Consulting* of Part 1 of China’s Center for Drug Evaluation (CDE)’s…
China / PhIRDA’s Song Ruilin on Strengthening Drug Supervision Capacity & Promoting Pharma Innovation
Song Ruilin, chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA), picks…
ASEAN / Regulatory Cooperation & Joint Assessments
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National…
Sweden / A Global Testbed for AMR Incentive Models
Anders Blanck, CEO of Lif, the trade association for the research-based Swedish pharmaceutical industry, writes…